Back
ESC2025 Premium Access

Emerging role of inflammatory pathways on coronary atherosclerotic risk in patients with chronic coronary syndromes under current treatment

Session: Lipid-lowering and inflammation
Topic: Inflammation and Immunity
Speaker: Doctor C. Caselli (Pisa, IT)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Chiara Caselli

CNR – National Research Council, Pisa (Italy)
0 follower

7 more presentations in this session

Association of colchicine with cardiovascular outcomes in patients with acute coronary syndrome

Speaker: Doctor M. Tao (Hartford, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Non-steroidal anti-inflammatory drug use after invasive and non-invasive diagnostic procedures for coronary artery disease by the degree of disease: a Danish drug utilization study (2008-2021)

Speaker: Doctor A. Bech-Drewes (Aarhus, DK)

Access
Abstract
Slides
Video
Like
Thumbnail

Healed plaque and systemic thrombogenicity in patients with chronic coronary syndrome

Speaker: Doctor D. Kinoshita (Yamagata, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

Effects of vitamin k2 and d3 supplementation on cardiac and systemic inflammation: a randomized controlled trial

Speaker: Doctor S. Hasific (Odense, DK)

Access
Abstract
Slides
Video
Like
Thumbnail

The impact of very highly elevated lipoprotein(a) levels on the early onset, complexity, and extent of coronary artery disease

Speaker: Mr C. Coerkamp (Amsterdam, NL)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Lipid-lowering and inflammation

Speakers: Doctor C. Caselli, Doctor M. Tao, Doctor A. Bech-Drewes, Doctor D. Kinoshita, Doctor S. Hasific...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources